LBA6Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. (17th December 2018) - Rizvi, N A; Chul Cho, B; Reinmuth, N; Lee, K H; Ahn, M-J; Luft, A; van den Heuvel, M; Cobo, M; Smolin, A; Vicente, D; Moiseyenko, V; Antonia, S J; et al.